These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9733371)

  • 1. A retrospective study of treatment of cerebral toxoplasmosis in AIDS patients with trimethoprim-sulphamethoxazole.
    Torre D; Speranza F; Martegani R; Zeroli C; Banfi M; Airoldi M
    J Infect; 1998 Jul; 37(1):15-8. PubMed ID: 9733371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis.
    Veenstra J; Veugelers PJ; Keet IP; van der Ven AJ; Miedema F; Lange JM; Coutinho RA
    Clin Infect Dis; 1997 May; 24(5):936-41. PubMed ID: 9142796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings).
    Dedicoat M; Livesley N
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005420. PubMed ID: 16856096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and good tolerance of cotrimoxazole as treatment of cerebral toxoplasmosis in AIDS].
    Smadja D; Fournerie P; Cabre P; Cabie A; Olindo S
    Presse Med; 1998 Sep; 27(26):1315-20. PubMed ID: 9779045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of trimethoprim-sulfamethoxazole in HIV-infected patients with cerebral toxoplasmosis in Brazil: a single-arm open-label clinical trial.
    Pellegrino D; Gryschek R; de Oliveira ACP; Marcusso R; Correia A; Vidal JE
    Int J STD AIDS; 2019 Oct; 30(12):1156-1162. PubMed ID: 31558125
    [No Abstract]   [Full Text] [Related]  

  • 6. Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group.
    Toma E; Thorne A; Singer J; Raboud J; Lemieux C; Trottier S; Bergeron MG; Tsoukas C; Falutz J; Lalonde R; Gaudreau C; Therrien R
    Clin Infect Dis; 1998 Sep; 27(3):524-30. PubMed ID: 9770152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
    Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
    Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group.
    Torre D; Casari S; Speranza F; Donisi A; Gregis G; Poggio A; Ranieri S; Orani A; Angarano G; Chiodo F; Fiori G; Carosi G
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1346-9. PubMed ID: 9624473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral trimethoprim-sulfamethoxazole in the treatment of cerebral toxoplasmosis in AIDS patients--a prospective study.
    Francis P; Patel VB; Bill PL; Bhigjee AI
    S Afr Med J; 2004 Jan; 94(1):51-3. PubMed ID: 14971234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia.
    Caumes E; Roudier C; Rogeaux O; Bricaire F; Gentilini M
    Clin Infect Dis; 1994 Mar; 18(3):319-23. PubMed ID: 8011811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebral toxoplasmosis in AIDS: efficacy and good tolerance of cotrimoxazole].
    Smadja D; Lin L; Cidolit E; Neisson-Vernant C; Cabre P; Vernant JC
    Presse Med; 1994 May; 23(19):907. PubMed ID: 7937621
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection.
    DiRienzo AG; van Der Horst C; Finkelstein DM; Frame P; Bozzette SA; Tashima KT
    AIDS Res Hum Retroviruses; 2002 Jan; 18(2):89-94. PubMed ID: 11839141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of HIV-associated central nervous system toxoplasmosis.
    Marra CM; Krone MR; Koutsky LA; Holmes KK
    Int J STD AIDS; 1998 Dec; 9(12):761-4. PubMed ID: 9874125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral trimethoprim-sulphamethoxazole levels in stable HIV-infected children.
    Zar HJ; Langdon G; Apolles P; Eley B; Hussey G; Smith P
    S Afr Med J; 2006 Jul; 96(7):627-9. PubMed ID: 16909188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization to trimethoprim-sulfamethoxazole in a toxoplasmic encephalitis patient who was intolerant to conventional treatments.
    Miyata N; Yoshimura Y; Hikosaka K; Norose K; Tachikawa N
    J Infect Chemother; 2020 Mar; 26(3):289-293. PubMed ID: 31711832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
    Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR
    Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute delirium induced by intravenous trimethoprim-sulfamethoxazole therapy in a patient with the acquired immunodeficiency syndrome.
    Salkind AR
    Hum Exp Toxicol; 2000 Feb; 19(2):149-51. PubMed ID: 10773846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The frequency of adverse reactions to sulfamethoxazole with trimethoprim and risk factors in HIV patients].
    Martínez-Martínez MC; Hernández-Morales MR; Mancilla-Hernández E
    Rev Alerg Mex; 2020; 67(2):96-101. PubMed ID: 32892524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?
    Hernandez AV; Thota P; Pellegrino D; Pasupuleti V; Benites-Zapata VA; Deshpande A; Penalva de Oliveira AC; Vidal JE
    HIV Med; 2017 Feb; 18(2):115-124. PubMed ID: 27353303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids.
    Arens J; Barnes K; Crowley N; Maartens G
    S Afr Med J; 2007 Oct; 97(10):956-8. PubMed ID: 18000578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.